Erratum: Design and rationale of japanese evaluation between formula of azelnidipine and amlodipine add on olmesartan to get antialbuminuric effect study (J-FLAG) : Ion of the antialbuminuric effects between calcium channel blocker with sympatholytic action in hypertensive patients with diabetes and albuminuria (Cardiovascular Drugs and Therapy (2011) 25 (365366) DOI 10.1007/s10557-011-6309-5))

Katsuyuki Ando; Masakazu Haneda; Sadayoshi Ito; Naoki Kashihara; Koichi Node; Masaomi Nangaku; Tatsuo Shimosawa; Junji Kishimoto; Toshiro Fujita

doi:10.1007/s10557-011-6315-7

Erratum: Design and rationale of japanese evaluation between formula of azelnidipine and amlodipine add on olmesartan to get antialbuminuric effect study (J-FLAG) : Ion of the antialbuminuric effects between calcium channel blocker with sympatholytic action in hypertensive patients with diabetes and albuminuria (Cardiovascular Drugs and Therapy (2011) 25 (365366) DOI 10.1007/s10557-011-6309-5))

Katsuyuki Ando, Masakazu Haneda, Sadayoshi Ito, Naoki Kashihara, Koichi Node, Masaomi Nangaku, Tatsuo Shimosawa, Junji Kishimoto, Toshiro Fujita

Leadership

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	365-366
Number of pages	2
Journal	Cardiovascular Drugs and Therapy
Volume	25
Issue number	4
DOIs	https://doi.org/10.1007/s10557-011-6315-7
Publication status	Published - 2011 Aug

ASJC Scopus subject areas

Pharmacology
Cardiology and Cardiovascular Medicine
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s10557-011-6315-7

Cite this

Ando, K., Haneda, M., Ito, S., Kashihara, N., Node, K., Nangaku, M., Shimosawa, T., Kishimoto, J., & Fujita, T. (2011). Erratum: Design and rationale of japanese evaluation between formula of azelnidipine and amlodipine add on olmesartan to get antialbuminuric effect study (J-FLAG) : Ion of the antialbuminuric effects between calcium channel blocker with sympatholytic action in hypertensive patients with diabetes and albuminuria (Cardiovascular Drugs and Therapy (2011) 25 (365366) DOI 10.1007/s10557-011-6309-5)). Cardiovascular Drugs and Therapy, 25(4), 365-366. https://doi.org/10.1007/s10557-011-6315-7

Erratum : Design and rationale of japanese evaluation between formula of azelnidipine and amlodipine add on olmesartan to get antialbuminuric effect study (J-FLAG) : Ion of the antialbuminuric effects between calcium channel blocker with sympatholytic action in hypertensive patients with diabetes and albuminuria (Cardiovascular Drugs and Therapy (2011) 25 (365366) DOI 10.1007/s10557-011-6309-5)). / Ando, Katsuyuki; Haneda, Masakazu; Ito, Sadayoshi; Kashihara, Naoki; Node, Koichi; Nangaku, Masaomi; Shimosawa, Tatsuo; Kishimoto, Junji; Fujita, Toshiro.

In: Cardiovascular Drugs and Therapy, Vol. 25, No. 4, 08.2011, p. 365-366.

Research output: Contribution to journal › Comment/debate › peer-review

Ando, K, Haneda, M, Ito, S, Kashihara, N, Node, K, Nangaku, M, Shimosawa, T, Kishimoto, J & Fujita, T 2011, 'Erratum: Design and rationale of japanese evaluation between formula of azelnidipine and amlodipine add on olmesartan to get antialbuminuric effect study (J-FLAG) : Ion of the antialbuminuric effects between calcium channel blocker with sympatholytic action in hypertensive patients with diabetes and albuminuria (Cardiovascular Drugs and Therapy (2011) 25 (365366) DOI 10.1007/s10557-011-6309-5))', Cardiovascular Drugs and Therapy, vol. 25, no. 4, pp. 365-366. https://doi.org/10.1007/s10557-011-6315-7

Ando K, Haneda M, Ito S, Kashihara N, Node K, Nangaku M et al. Erratum: Design and rationale of japanese evaluation between formula of azelnidipine and amlodipine add on olmesartan to get antialbuminuric effect study (J-FLAG) : Ion of the antialbuminuric effects between calcium channel blocker with sympatholytic action in hypertensive patients with diabetes and albuminuria (Cardiovascular Drugs and Therapy (2011) 25 (365366) DOI 10.1007/s10557-011-6309-5)). Cardiovascular Drugs and Therapy. 2011 Aug;25(4):365-366. https://doi.org/10.1007/s10557-011-6315-7

Ando, Katsuyuki ; Haneda, Masakazu ; Ito, Sadayoshi ; Kashihara, Naoki ; Node, Koichi ; Nangaku, Masaomi ; Shimosawa, Tatsuo ; Kishimoto, Junji ; Fujita, Toshiro. / Erratum : Design and rationale of japanese evaluation between formula of azelnidipine and amlodipine add on olmesartan to get antialbuminuric effect study (J-FLAG) : Ion of the antialbuminuric effects between calcium channel blocker with sympatholytic action in hypertensive patients with diabetes and albuminuria (Cardiovascular Drugs and Therapy (2011) 25 (365366) DOI 10.1007/s10557-011-6309-5)). In: Cardiovascular Drugs and Therapy. 2011 ; Vol. 25, No. 4. pp. 365-366.

@article{b03afdf229404369a30c12c564797fa8,

title = "Erratum: Design and rationale of japanese evaluation between formula of azelnidipine and amlodipine add on olmesartan to get antialbuminuric effect study (J-FLAG) : Ion of the antialbuminuric effects between calcium channel blocker with sympatholytic action in hypertensive patients with diabetes and albuminuria (Cardiovascular Drugs and Therapy (2011) 25 (365366) DOI 10.1007/s10557-011-6309-5))",

author = "Katsuyuki Ando and Masakazu Haneda and Sadayoshi Ito and Naoki Kashihara and Koichi Node and Masaomi Nangaku and Tatsuo Shimosawa and Junji Kishimoto and Toshiro Fujita",

year = "2011",

month = aug,

doi = "10.1007/s10557-011-6315-7",

language = "English",

volume = "25",

pages = "365--366",

journal = "Cardiovascular Drugs and Therapy",

issn = "0920-3206",

publisher = "Kluwer Academic Publishers",

number = "4",

}

TY - JOUR

T1 - Erratum

T2 - Design and rationale of japanese evaluation between formula of azelnidipine and amlodipine add on olmesartan to get antialbuminuric effect study (J-FLAG) : Ion of the antialbuminuric effects between calcium channel blocker with sympatholytic action in hypertensive patients with diabetes and albuminuria (Cardiovascular Drugs and Therapy (2011) 25 (365366) DOI 10.1007/s10557-011-6309-5))

AU - Ando, Katsuyuki

AU - Haneda, Masakazu

AU - Ito, Sadayoshi

AU - Kashihara, Naoki

AU - Node, Koichi

AU - Nangaku, Masaomi

AU - Shimosawa, Tatsuo

AU - Kishimoto, Junji

AU - Fujita, Toshiro

PY - 2011/8

Y1 - 2011/8

UR - http://www.scopus.com/inward/record.url?scp=80052280847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052280847&partnerID=8YFLogxK

U2 - 10.1007/s10557-011-6315-7

DO - 10.1007/s10557-011-6315-7

M3 - Comment/debate

AN - SCOPUS:80052280847

VL - 25

SP - 365

EP - 366

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

SN - 0920-3206

IS - 4

ER -

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this